Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.86 is 58% above its 2-year average of 2.45, near the high end of its 2-year range (0.00–3.86).
As of the fiscal period ended Tuesday, March 31, 2026. 18.41% above its 12-month average of 3.26.
Reported quarterly current ratio; no daily interpolation. Q4 FY2026 (2026-03-31): 3.86.
CURRENT RATIO
3.86
CURRENT RATIO AVG TTM
3.26
CURRENT RATIO AVG 3Y
N/A
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+18.41%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 571 covered companies
CURRENT VS SECTOR MEDIAN
+15.20%
vs the sector median at left
Cellyan Biotechnology Co., Ltd
Market Cap
$1.11M
Current Ratio
3.86
TTM Avg
3.26
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.16M
Current Ratio
0.66
TTM Avg
1.48
3Y Avg
0.74
5Y Avg
0.53
Market Cap
$1.02M
Current Ratio
7.99
TTM Avg
0.13
3Y Avg
1.02
5Y Avg
1.02
Market Cap
$898130.00
Current Ratio
8.67
TTM Avg
12.04
3Y Avg
7.97
5Y Avg
19.74
Market Cap
$880673.00
Current Ratio
1.83
TTM Avg
2.05
3Y Avg
3.13
5Y Avg
5.42
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cellyan Biotechnology Co., Ltd (HKPD) | $1.11M | 3.86 | 3.26 | N/A | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.10M | 4.31 | 1.47 | 1.08 | 7.17 |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.16M | 0.66 | 1.48 | 0.74 | 0.53 |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | 7.99 | 0.13 | 1.02 | 1.02 |
| IM Cannabis Corp. (IMCC)vs › | $1.19M | 0.56 | 0.67 | 0.76 | 1.51 |
| Genprex, Inc. (GNPX)vs › | $1.31M | 6.77 | 2.33 | 3.65 | 17.91 |
| Bone Biologics Corporation (BBLG)vs › | $898130.00 | 8.67 | 12.04 | 7.97 | 19.74 |
| GlucoTrack, Inc. (GCTK)vs › | $893920.00 | 0.46 | 3.06 | 2.92 | 4.37 |
| Decoy Therapeutics Inc. (DCOY)vs › | $880673.00 | 1.83 | 2.05 | 3.13 | 5.42 |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.38M | 3.00 | 0.80 | 7.12 | 9.62 |
Current Ratio
3.86
Quick Ratio
3.75
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-03-31 | 3.86 |
| 2025-09-30 | 2.93 |
| 2025-03-31 | 2.99 |
| 2024-09-30 | 2.46 |
| 2024-03-31 | 2.46 |
| 2023-09-30 | 0.00 |
